Literature DB >> 10329740

Primary central nervous system lymphoma.

L M DeAngelis.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10329740      PMCID： PMC1736370          DOI： 10.1136/jnnp.66.6.699

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study.

Authors:  R Velasco; S Mercadal; F Graus; N Vidal; M Alañá; M I Barceló; M J Ibáñez-Juliá; S Bobillo; R Caldú Agud; E García Molina; P Martínez; P Cacabelos; A Muntañola; G García-Catalán; J M Sancho; I Camro; T Lado; M E Erro; L Gómez-Vicente; A Salar; A C Caballero; M Solé-Rodríguez; J Gállego Pérez-Larraya; N Huertas; J Estela; M Barón; N Barbero-Bordallo; M Encuentra; I Dlouhy; J Bruna
Journal:  J Neurooncol       Date:  2020-06-10       Impact factor: 4.130

2.  White matter lesions and encephalopathy in patients treated for primary central nervous system lymphoma.

Authors:  M W Wassenberg; J E Bromberg; T D Witkamp; C H Terhaard; M J Taphoorn
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

3.  BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma.

Authors:  Markus Krumbholz; Diethilde Theil; Tobias Derfuss; Andreas Rosenwald; Frank Schrader; Camelia-Maria Monoranu; Susan L Kalled; Donna M Hess; Barbara Serafini; Francesca Aloisi; Hartmut Wekerle; Reinhard Hohlfeld; Edgar Meinl
Journal:  J Exp Med       Date:  2005-01-10       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.